Document is current
Any future updates will be listed below
-
Authors
Schmoranz, Kerstin
Schötz, Cathrin
Merkel, Daniel
Lüftner, Diana
- License Information
-
More Information
Article History
Received: 21 May 2023
Accepted: 22 July 2023
First Online: 29 July 2023
Declarations
:
: The authors declare no competing interests.
: Prof. Dr. med. Diana Lüftner received honoraria for advisory board activities and oral presentations from Amgen, AstraZeneca, Daiichi Sankyo, Eli Lilly, Gilead, GSK, high5md, Loreal, MSD, Novartis, onkowissen, Pfizer, Roche, Teva and Viatris. Kerstin Schmoranz received honoraria for oral presentations from onkowissen.de. Cathrin Schötz has no conflicts of interest to declare. Dr. med. Daniel Merkel has no conflicts of interest to declare.
